349 related articles for article (PubMed ID: 18995950)
1. Neoadjuvant chemotherapy: a new treatment paradigm for muscle-invasive bladder cancer.
Herr HW
Eur Urol; 2009 Feb; 55(2):303-5; discussion 305-6. PubMed ID: 18995950
[No Abstract] [Full Text] [Related]
2. Neoadjuvant chemotherapy in the management of muscle-invasive bladder cancer.
Dreicer R
Semin Urol Oncol; 2001 Aug; 19(3):180-5. PubMed ID: 11561985
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy in patients with invasive bladder cancer.
Vaughn DJ; Malkowicz SB
Urol Clin North Am; 2005 May; 32(2):231-7. PubMed ID: 15862620
[TBL] [Abstract][Full Text] [Related]
4. Baseline renal function status limits patient eligibility to receive perioperative chemotherapy for invasive bladder cancer and is minimally affected by radical cystectomy.
Canter D; Viterbo R; Kutikov A; Wong YN; Plimack E; Zhu F; Oblaczynski M; Berberian R; Chen DY; Greenberg RE; Uzzo RG; Boorjian SA
Urology; 2011 Jan; 77(1):160-5. PubMed ID: 20709369
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer.
Muramaki M; Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
Int J Urol; 2008 Apr; 15(4):314-8. PubMed ID: 18380818
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy is not (yet) standard treatment for muscle-invasive bladder cancer.
Sternberg CN; Parmar MK
J Clin Oncol; 2001 Sep; 19(18 Suppl):21S-26S. PubMed ID: 11560967
[No Abstract] [Full Text] [Related]
7. Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation.
Sternberg CN
Semin Oncol; 2007 Apr; 34(2):122-8. PubMed ID: 17382795
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant and adjuvant chemotherapy for invasive bladder cancer.
Smith MR; Kantoff PW
Semin Oncol; 1995 Dec; 22(6):625-32. PubMed ID: 8539637
[TBL] [Abstract][Full Text] [Related]
9. Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.
Milowsky MI; Stadler WM; Bajorin DF
BJU Int; 2008 Nov; 102(9 Pt B):1339-44. PubMed ID: 19035902
[TBL] [Abstract][Full Text] [Related]
10. Editorial comment.
O'Donnell PH; Posadas EM
Urology; 2011 Jan; 77(1):165-6. PubMed ID: 21195839
[No Abstract] [Full Text] [Related]
11. Muscle-invasive urothelial carcinoma of the bladder: neoadjuvant chemotherapy enables organ-preserving therapy in carefully selected patients.
Heidenreich A
Eur Urol; 2008 Jul; 54(1):21-3. PubMed ID: 18262722
[No Abstract] [Full Text] [Related]
12. Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer.
Calabrò F; Sternberg CN
Eur Urol; 2009 Feb; 55(2):348-58. PubMed ID: 18977070
[TBL] [Abstract][Full Text] [Related]
13. [Neoadjuvant cisplatin chemotherapy and radical cystectomy in bladder carcinoma].
Dunst J
Strahlenther Onkol; 1996 Aug; 172(8):463-4. PubMed ID: 8765352
[No Abstract] [Full Text] [Related]
14. Outcome of patients who refuse cystectomy after receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer.
Herr HW
Eur Urol; 2008 Jul; 54(1):126-32. PubMed ID: 18248875
[TBL] [Abstract][Full Text] [Related]
15. The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer.
deVere White RW; Katz MH; Steinberg GD
J Urol; 2009 May; 181(5):1994-7. PubMed ID: 19286209
[No Abstract] [Full Text] [Related]
16. Rebuttal from author re: Axel Heidenreich. Muscle-invasive urothelial carcinoma of the bladder: neoadjuvant chemotherapy enables organ preserving therapy in carefully selected patients. Eur Urol 2008;54:21-23.
Herr HW
Eur Urol; 2008 Jul; 54(1):23-4. PubMed ID: 18262335
[No Abstract] [Full Text] [Related]
17. Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer.
Clark PE
Expert Rev Anticancer Ther; 2009 Jun; 9(6):821-30. PubMed ID: 19496719
[TBL] [Abstract][Full Text] [Related]
18. Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy.
Kaufman DS; Winter KA; Shipley WU; Heney NM; Wallace HJ; Toonkel LM; Zietman AL; Tanguay S; Sandler HM
Urology; 2009 Apr; 73(4):833-7. PubMed ID: 19100600
[TBL] [Abstract][Full Text] [Related]
19. Advances in the management of muscle-invasive bladder cancer through risk prediction, risk communication, and novel treatment approaches.
Galsky MD; Domingo-Domenech J
Clin Adv Hematol Oncol; 2013 Feb; 11(2):86-92. PubMed ID: 23598909
[TBL] [Abstract][Full Text] [Related]
20. The role of neoadjuvant chemotherapy for invasive bladder cancer.
Martínez-Piñeiro JA; Martínez-Piñeiro L
Br J Urol; 1998 Jul; 82(1):33-42. PubMed ID: 9698660
[No Abstract] [Full Text] [Related]
[Next] [New Search]
